Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.77 USD | -0.13% | -1.77% | -26.99% |
04-17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
04-15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- WKME Stock
- Revisions WalkMe Ltd.